-
SPRTN Ubiquitin Binding Enables Rapid DPC Proteolysis
2026-09-12
The reference preprint identifies a ubiquitin-binding region within the N-terminal catalytic domain of SPRTN, showing how ubiquitination directs this protease toward DNA-protein crosslinks (DPCs). Its central result is that ubiquitin-chain engagement increases SPRTN proteolysis of polyubiquitinated DPCs by approximately 67-fold relative to unmodified lesions, providing a mechanistic explanation for rapid substrate selection.
-
From 2-DG Signal to Translational Metabolism
2026-09-11
A mechanistic and strategic guide to using the WST-8 Glucose Uptake Assay Kit for linking cellular glucose handling with nucleic acid delivery, cancer metabolism research, diabetes research, and metabolic disease models.
-
Cisplatin Beyond Cytotoxicity: A Translational Lens
2026-09-11
Cisplatin and CDDP remain powerful mechanistic probes for DNA damage, apoptosis, tumor biology, and chemotherapy resistance. New HNSCC findings position the SIA-cIgG/PTPN13 axis as a biomarker-informed framework for improving cisplatin response while patient-derived organoids and xenografts help connect molecular insight to translational decisions.
-
Tobramycin Assay Design for Resistance Research
2026-09-10
Build more interpretable Tobramycin susceptibility assays by combining water-based preparation, controlled microtiter conditions, and resistance-aware comparisons. This practical guide translates a classic aminoglycoside study into reproducible workflows for Gram-negative microbiology and antibiotic resistance research.
-
Biotin-tyramide for Spatial Checkpoint Biology
2026-09-10
Biotin-tyramide can convert HRP recognition into a spatially amplified readout for difficult immunology assays. This article explains how to use the reagent to interrogate PD-L1 biology while separating localization evidence from claims about degradation or recycling.
-
HyperFluor 488 Goat Anti-Rabbit IgG Guide
2026-09-09
HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody provides fluorescent detection of rabbit IgG primary antibodies in immunofluorescence, immunohistochemistry, immunocytochemistry, microscopy, and flow cytometry workflows. It should be used with rabbit primary antibodies and assay conditions compatible with its glycerol, BSA, and sodium azide-containing buffer, not as a universal secondary for non-rabbit or enzyme-based detection systems.
-
L-NMMA acetate for NO Pathway Assays
2026-09-09
L-NMMA acetate provides a practical pharmacological test of whether nitric oxide signaling is causally involved in osteogenic, inflammatory, or vascular phenotypes. This workflow translates evidence from dental follicle cell research into controlled dose–response experiments, matched readouts, and troubleshooting strategies.
-
Z-LEHD-FMK: Irreversible Caspase-9 Inhibitor
2026-09-08
Z-LEHD-FMK helps separate mitochondria-mediated apoptosis from caspase-1-driven pyroptosis in cell-death experiments. This workflow-focused guide covers stock preparation, apoptosis assay design, cancer research applications, and troubleshooting for mechanistic caspase studies.
-
Regorafenib Workflows for Melanoma Research
2026-09-08
Build mechanism-focused melanoma, angiogenesis, and motility assays with Regorafenib (BAY 73-4506), from controlled DMSO preparation to tumor xenograft models. The workflow connects phenotypic responses with RRM2 and ERK/E2F3 readouts, helping distinguish direct growth suppression from broader anti-invasive effects.
-
Oleanolic Acid: From Mechanism to Liposome Assays
2026-09-07
Oleanolic acid is a natural triterpenoid of interest in inducible nitric oxide synthase induction, antiviral research, and immune pathway studies. This article connects its biological profile with a decision-focused nanoparticle exclusion chromatography workflow for measuring encapsulation in dual-loaded liposomes.
-
Forskolin: Adenylate Cyclase Activator Guide
2026-09-05
Forskolin is a direct adenylate cyclase activator that elevates intracellular cAMP and supports mechanistic studies of inflammation, stem-cell biology, neuroendocrine secretion, and cardiovascular disease research. Its experimental value depends on solvent control, assay-specific dose optimization, and separation of product evidence from disease-treatment claims.
-
Perphenazine Workflows for D2 Receptor Research
2026-09-05
Perphenazine combines dopamine D2 receptor antagonism with phenothiazine polypharmacology, enabling linked workflows in neuropharmacology, mitochondrial stress biology, and macrophage host-defense research. This guide translates published findings into practical assay designs, controls, and troubleshooting checkpoints without treating exploratory data as clinical evidence.
-
Ceftazidime in Gram-Negative Resistance Research
2026-09-04
Ceftazidime provides a practical phenotype layer for studying Gram-negative susceptibility, especially Pseudomonas aeruginosa, while revealing where β-lactamase-mediated resistance limits interpretation. This workflow connects broth microdilution with plasmid, PCR, and strain-typing data from a multicenter CREC study.
-
CHK1 Inhibition in ER/PR-Stratified Breast Cancer
2026-09-04
The 2020 reference study shows that CHK1 inhibition does not produce a uniform response across breast cancer subtypes: it sensitizes ER−/PR−/HER2− models to adriamycin but has mainly single-agent activity in ER+/PR+/HER2− models. Integrated database, transcriptomic, cell-cycle, apoptosis, and drug-sensitivity analyses connect these outcomes to distinct checkpoint, mitotic, and death-signaling mechanisms.
-
MDM1, p53, and Chemoradiotherapy Sensitivity in CRC
2026-09-03
A 2025 Cancer Biology & Medicine study identifies MDM1 as a functional regulator and potential biomarker of colorectal cancer chemoradiotherapy response. Its experiments connect MDM1 overexpression with reduced YBX1 occupancy at the TP53 promoter, higher p53 expression, and stronger apoptosis after treatment, while suggesting a rationale for biomarker-guided combination strategies.